These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 21459963)
21. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Keogh KA; Wylam ME; Stone JH; Specks U Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078 [TBL] [Abstract][Full Text] [Related]
22. Use of N-acetylcysteine in the management of coronary artery diseases. Marchetti G; Lodola E; Licciardello L; Colombo A Cardiologia; 1999 Jul; 44(7):633-7. PubMed ID: 10476588 [TBL] [Abstract][Full Text] [Related]
25. An atypical cutaneous presentation of vasculitis with features of Churg-Strauss syndrome, associated with anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies. Gleeson CM; Levy JB; Cook HT; Francis ND; Robson A; Pope FM Clin Exp Dermatol; 2009 Dec; 34(8):e577-80. PubMed ID: 19558532 [TBL] [Abstract][Full Text] [Related]
26. Cytoplasmic antineutrophil cytoplasmic antibody-positive vasculitis associated with ulcerative colitis. Weir A; Taylor-Robinson SD; Poole S; Pignatelli M; Walters JF; Calam J Am J Gastroenterol; 1997 Mar; 92(3):506-8. PubMed ID: 9068480 [TBL] [Abstract][Full Text] [Related]
27. [Thrombolytic therapy of vasculitis and thrombotic microangiopathy--with special reference to the kidney]. Mitarai T Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1634-8. PubMed ID: 9410974 [No Abstract] [Full Text] [Related]
28. Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis. Jennette JC; Falk RJ Curr Opin Rheumatol; 1992 Feb; 4(1):9-15. PubMed ID: 1543669 [TBL] [Abstract][Full Text] [Related]
29. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy? Flossmann O; de Groot K Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358 [No Abstract] [Full Text] [Related]
30. Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation. Chavele KM; Shukla D; Keteepe-Arachi T; Seidel JA; Fuchs D; Pusey CD; Salama AD Arthritis Rheum; 2010 May; 62(5):1539-48. PubMed ID: 20155828 [TBL] [Abstract][Full Text] [Related]
32. Targeting B lymphocytes as therapy for ANCA-associated vasculitis. Golbin JM; Specks U Rheum Dis Clin North Am; 2007 Nov; 33(4):741-54, v. PubMed ID: 18037114 [TBL] [Abstract][Full Text] [Related]
33. Microscopic polyangitis triggered by fungal infection. Kon Y; Bohgaki M; Notoya A; Mukai M; Kohno M; Sato H Hokkaido Igaku Zasshi; 2006 Jan; 81(1):5-8. PubMed ID: 16528974 [TBL] [Abstract][Full Text] [Related]
34. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482 [TBL] [Abstract][Full Text] [Related]
35. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573 [TBL] [Abstract][Full Text] [Related]
36. Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approaches to management. Little MA; Pusey CD Nephrology (Carlton); 2005 Aug; 10(4):368-76. PubMed ID: 16109084 [TBL] [Abstract][Full Text] [Related]
38. [Towards evidence-based therapy in primary systemic vasculitis. Progress during the past decades have improved the situations of today's patients]. Segelmark M; Westman K Lakartidningen; 2007 Mar 21-27; 104(12):954-7. PubMed ID: 17469311 [No Abstract] [Full Text] [Related]